Document Detail


Results of the implementation of liquid-based cytology-SurePath in the Ontario screening program.
MedLine Citation:
PMID:  15481083     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The objective of the current study was to evaluate the adequacy and detection rates of SurePath after its implementation in Ontario. METHODS: The detection and adequacy rates of the SurePath liquid-based cytology system (SP-LBC) were calculated for manually reviewed slides of the year 2002. The adequacy and detection rates from this study group were compared with a historical conventional smear (CS) group from the same laboratories during the same period of the previous year. RESULTS: The SP-LBC study group consisted of 352,680 specimens with cytodiagnoses and the CS group included 378,990 specimens. The unsatisfactory rate for SP-LBC (0.24%) was less than that of the CS group (0.58%). The detection rate of atypical squamous cells (ASC+) by the SP-LBC group (4.69%) was greater than that of the CS group (3.81%), as was the detection rate of low-grade squamous intraepithelial lesions (LSIL+; 2.13% vs. 1.50% in the CS group). There was only a trend toward increased detection of high-grade squamous intraepithelial lesions (HSIL+) in the SP-LBC group (0.34%) relative to the CS group (0.31%), because the detection rate for carcinoma by SP-LBC declined. CONCLUSIONS: The implementation of SP-LBC has been followed by better specimen adequacy and detection rates for ASC+, LSIL+, and a trend of increased detection of HSIL+ relative to CS practice. To determine sensitivity rates, a histopathologic database for cervical carcinoma and precancer needs to be established.
Authors:
Terence J Colgan; C Meg McLachlin; Michelle Cotterchio; Robbi Howlett; Allan M Seidenfeld; Verna M Mai
Related Documents :
17534393 - Neoadjuvant cisplatin and radical cesarean hysterectomy for cervical cancer in pregnancy.
9539523 - Cervical fetal fibronectin correlates to prostaglandin e2-induced cervical ripening and...
11598363 - Effect of betamethasone on computerized cardiotocographic parameters in preterm growth-...
Publication Detail:
Type:  Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Cancer     Volume:  102     ISSN:  0008-543X     ISO Abbreviation:  Cancer     Publication Date:  2004 Dec 
Date Detail:
Created Date:  2004-12-16     Completed Date:  2005-01-11     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0374236     Medline TA:  Cancer     Country:  United States    
Other Details:
Languages:  eng     Pagination:  362-7     Citation Subset:  AIM; IM    
Affiliation:
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada. tcolgan@mtsinai.on.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Carcinoma, Squamous Cell / diagnosis*
Female
Humans
Mass Screening*
Microtomy*
Observer Variation
Ontario
Reproducibility of Results
Sensitivity and Specificity
Specimen Handling
Uterine Cervical Neoplasms / diagnosis*
Vaginal Smears / standards*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Successful engraftment following unrelated donor transplant in an alloimmunized patient with Kostman...
Next Document:  Ion activation methods for tandem mass spectrometry.